Semler Scientific, Inc. (SMLR)

Market Cap	456.23M
Revenue (ttm)	56.29M
Net Income (ttm)	40.90M
Shares Out	9.56M
EPS (ttm)	5.13
PE Ratio	9.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	268,331
Open	53.12
Previous Close	52.24
Day's Range	47.61 - 53.27
52-Week Range	20.88 - 81.56
Beta	1.18
Analysts	Strong Buy
Price Target	71.00 (+48.72%)
Earnings Date	Feb 18, 2025

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 92
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2024, Semler Scientific's revenue was $56.29 million, a decrease of -17.44% compared to the previous year's $68.18 million. Earnings were $40.90 million, an increase of 98.70%.

Analyst Forecast

According to one analyst, the rating for SMLR stock is "Strong Buy" and the 12-month stock price forecast is $71.0.

Price Target

$71.0

(48.72% upside)

Analyst Consensus: Strong Buy